Showing results (221-230 of 523) with videos related to
Sort By:
Pageof 53
Acta Neuropathologica|January 1, 1995
Immunoreactivity of the central nervous system in cats with a Borna disease-like meningoencephalomyelitis (staggering disease)A L Lundgren, R Lindberg, H Ludwig, et al.Wiener Klinische Wochenschrift|October 27, 1978
[The influence of metabolic control on chemotactic activity in insulin-dependent diabetes mellitus (author's transl)]A T Endler, C Zielinski, G Schernthaner, et al.Journal of Vision|January 17, 2009
Oculomotor capture by transient events: a comparison of abrupt onsets, offsets, motion, and flickerCasimir J H Ludwig, Adam Ranson, Iain D GilchristDiabete & Metabolisme|September 1, 1977
Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathyG Schernthaner, H Ludwig, W R Mayr, et al.Diabete & Metabolisme|September 1, 1978
Humoral antibacterial immunity in first degree relatives of insulin-dependent diabeticsG Schernthaner, H Ludwig, W R Mayr, et al.Vision Research|October 31, 2006
Limited flexibility in the filter underlying saccadic targetingCasimir J H Ludwig, Miguel P Eckstein, Brent R BeutterJournal of Neurophysiology|November 17, 2006
A population coding account for systematic variation in saccadic dead timeCasimir J H Ludwig, John W Mildinhall, Iain D GilchristCurrent Medical Research and Opinion|April 7, 2005
Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agentS Amadori, P Fenaux, H Ludwig, et al.Blut|September 1, 1987
VAD protocol for treatment of advanced refractory multiple myelomaW Scheithauer, A Cortelezzi, R Kutzmits, et al.Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|March 1, 1976
[Microfluorometric demonstration of thyroglobulin antibodies with the defined antigen substrate spheres (DASS) system]W Knapp, H Ludwig, G Schernthaner, et al.Pageof 53